Biohaven ALS drug blocked by FDA over manufacturing issueBiohaven’s therapy for amyotrophic lateral sclerosis (ALS) has been rejected by the FDA over manufacturing compliance issues for Share XBiohaven ALS drug blocked by FDA over manufacturing issuehttps://pharmaphorum.com/news/biohaven-als-drug-blocked-by-fda-over-manufacturing-issue/
